The annual multidisciplinary Uro-oncology Congress was held on 06-08 September 1402 by the Genitourinary Tract Cancer Research Center. In this national congress, about 600 specialists from the fields of urology, pathology, radio-oncology and medical oncology were presented and exchanged information and experiences in this field. also veterans and active philanthropists in the field of genitourinary cancers were appreciated. Actero Company As one of the manufacturers of oncology products in Iran, played its role in improving the scientific and therapeutic level of the country with its presence and support of the Urinary Tract Cancer Association

Specialists at a pharmaceutical company have developed two new drugs to treat high blood pressure, a condition that affects approximately 32 million Iranians to varying degrees. The CEO of Actoverco pharmaceutical group, Reza Karimi Mostofi, reported that the specialists of his group have successfully provided the blood pressure medication Telmic-H to patients in Iran. Telmic-H is the first medication of its kind in Iran, containing telmisartan/hydrochlorothiazide. This medication comes in the form of coated tablets in two strengths: 80/12.5 and 80/25 mg. It is commonly used to treat high blood pressure. He stated that approximately 32 million people in Iran suffer from high blood pressure, which is one of the leading causes of cardiovascular diseases, including heart attacks, strokes, and fatalities resulting from these conditions.Cardiovascular accidents tend to occur more frequently in the early morning hours when the balance of certain hormones in the body is disrupted. Telmisartan/hydrochlorothiazide Actoverco medicine has several benefits, including constant monitoring of blood pressure, especially during sleep at night and in the early morning, which helps in maintaining a healthy blood pressure level. Mostofi stated that taking this medication can regulate blood pressure for 24 hours and minimize side effects. He mentioned that the company has introduced another new medicine named Irbesal (Irbesartan) at the Salamat Bonyan exhibition of science-based products in the field of food, medicine, and medical equipment. Irbesal is available in the form of coated and lined tablets of 300mg. Actoverco’s CEO stated that this drug is used to treat high blood pressure and diabetic nephropathy. He pointed out that high blood pressure, which unfortunately is quite prevalent in the country, is one of the leading causes of cardiovascular and kidney diseases. He affirmed that high blood pressure complications in diabetic patients, with uncontrolled high blood sugar, can cause damage to the kidney vessels and cells. This damage to cells will eventually lead to kidney failure.In addition to controlling blood pressure, Irbesartan can be effective in preventing diabetic nephropathy, which is the excretion of protein from the kidneys. The CEO of Actoverco Pharmaceuticals has stated that their company produces almost 400 different pharmaceutical products across 15 therapeutic areas. These products range from general disease treatments to high-risk oncology, hormonal, and biological drugs. The pharmaceutical complex is also involved in producing raw materials and supplements. To support the development of knowledge-based activities in the healthcare field, the Actotech accelerator has been launched. Mostofi stated that the knowledge-based complex became operational in 2020. The complex was inaugurated by the president’s scientific and technological deputy and the secretary of the biotechnology development staff. Currently, it is an advanced research and development complex that fulfills the requirements of a science and technology park. It supports the commercialization of innovative ideas across various fields, such as biotechnology drugs, vaccines, new drug formulations, personalized medicine, smart health, diagnostic kits, food quality control, as well as the field of raw materials, and factory production line equipment.

Merck, a German company, is one of the oldest manufacturers of drugs, chemicals, and health materials globally, and it is a leading name in the research and development (R&D) field in these sectors. The company exports its products to over 60 countries worldwide and is renowned for its innovative technology in the pharmaceutical industry. Merck’s production groups manufacture over 20,000 specialized pharmaceuticals, laboratory products, and special chemicals across various sectors. This company has started its activity in the field of trading and selling drugs in Iran since 1968. Actover Pharmaceutical Company has been successfully present in the Iranian pharmaceutical market for over half a century. They have achieved this with the help of the highest standards and the most advanced technologies and equipment in the world. As a result, they have gained the attention of major foreign companies, including Merck. Actovar is a company committed to producing high-quality pharmaceutical products using the latest technology, expert personnel, and smart selection of new products. It is proud to have obtained the highest quality standards and approvals, making it a capable partner of Merck in Iran and the surrounding region. It’s partnership allows it to produce drugs for this large German company and provide easy and affordable access to the latest pharmaceutical innovations from Merck